Lv1
100 积分 2024-06-25 加入
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumors
3个月前
已关闭
Trastuzumab pamirtecan (DB-1303/BNT323) in patients with previously treated HER2-expressing advanced/metastatic endometrial cancer: First global clinical phase 2 data
3个月前
已关闭
PD-1, BTLA and TIGIT as therapeutic targets for rheumatic disease
5个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
8个月前
已完结
The spatial and temporal activation of macrophages during fibrosis
9个月前
已完结
TL1A Promotes Fibrogenesis in Colonic Fibroblasts via the TGF-β1/Smad3 Signaling Pathway
10个月前
已完结
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?
11个月前
已完结
Fibrosis: cross-organ biology and pathways to development of innovative drugs
1年前
已完结
Fibrosis: cross-organ biology and pathways to development of innovative drugs
1年前
已关闭
The Immunopathophysiology of Organ Fibrosis: from Mechanisms to Immunotherapies
1年前
已完结
皖公网安备34019202002308
